What are the latest figures on the custom antibody market’s size and projected CAGR?
The custom antibody market size has grown rapidly in recent years. It will grow from $0.42 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to rising demand for custom antibodies, growing use of precision medicine, increasing prevalence of chronic diseases and cancer, increase in the number of research and development activities, and growing number of clinical trials.
The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to rising adoption of targeted immunotherapy, growing investment in biopharmaceuticals, increasing prevalence of neurodegenerative diseases, increasing demand for in vitro diagnostics (IVD) applications, and increasing healthcare expenditures. Major trends in the forecast period include personalized medicine, technological advancements in antibody engineering, advancements in biotechnology and genetic engineering, expanding therapeutic applications, and technological advancements in the purification of antibodies.
Get Your Free Sample of The Global Custom Antibody Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21162&type=smp
Which Market drivers have played a significant role in driving the custom antibody market?
The growing demand for personalized medicine is expected to propel the growth of the custom antibody market going forward. Personalized medicine refers to a medical approach that tailor’s treatment and prevention strategies to an individual’s genetic makeup, lifestyle, and environmental factors. The growing demand for personalized medicine is attributed to advancements in genomics, increased availability of biomarker-based therapies, and rising consumer preference for tailored treatment options that improve efficacy and reduce adverse effects. Custom antibody enables personalized medicine by providing particular and tailored immune reagents that enhance disease detection, therapeutic targeting, and biomarker identification for individualized treatment strategies. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, an increase from 6 in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the custom antibody market.
What are the key segments within the custom antibody market?
The custom antibody market covered in this report is segmented –
1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types
2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling
3) By Source: Mice, Rabbit, Other Sources
4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics
Subsegments:
1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies
2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies
3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments
4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/custom-antibody-global-market-report
Which key players are shaping the custom antibody market?
Major companies operating in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS
Which transformative trends will shape the custom antibody market landscape?
Major companies operating in the custom antibody market are focusing on integrating innovative technologies such as artificial intelligence to enhance antibody discovery, improve specificity, and accelerate development processes. Artificial intelligence supports custom antibody development by enhancing antigen selection, predicting antibody-antigen binding, and streamlining candidate screening with machine learning, leading to faster and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, launched with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon’s proprietary technology assembles antibodies into cage structures, allowing modifications to their properties without altering their core structures. This innovation aims to enhance antibody affinity for therapeutic targets while reducing off-target interactions, improving efficacy and safety.
How do regional factors impact the custom antibody market, and which region is the largest contributor?
North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Custom Antibody Market Report 2025 Offer?
The custom antibody market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A custom antibody is a laboratory-produced antibody specifically designed and generated to target a particular antigen of interest. These antibodies are tailored for research, diagnostic, or therapeutic applications based on the unique needs of scientists or healthcare professionals. Custom antibodies are widely used in biomedical research, diagnostics, and drug development, enabling precise detection and targeting of biomolecules.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21162
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
